A carregar...
The RareCyte® platform for next‐generation analysis of circulating tumor cells
Circulating tumor cells (CTCs) can reliably be identified in cancer patients and are associated with clinical outcome. Next‐generation “liquid biopsy” technologies will expand CTC diagnostic investigation to include phenotypic characterization and single‐cell molecular analysis. We describe here a r...
Na minha lista:
| Publicado no: | Cytometry A |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586054/ https://ncbi.nlm.nih.gov/pubmed/30277660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.a.23619 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|